Biogen





Ebitda Changement Date
AbbVie USD 3.52B 828M 2025-09
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
ALKERMES USD 121.55M 4.99M 2025-09
Amgen USD 5.14B 775M 2025-12
Bayer EUR 1.51B 1.28B 2025-09
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD -5.26M 300.71M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Esperion Therapeutics USD -27.51M 9.5M 2023-09
Gilead Sciences USD 4.03B 628M 2025-09
Incyte USD 414.5M 92.42M 2025-12
Merck USD 8.39B 1.97B 2025-09
Moderna USD -790M 582M 2025-12
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.88B 290M 2025-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD 20.63M 53.74M 2025-09
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sanofi EUR 4.84B 2.95B 2025-09
Sanofi EUR 5.66B 3.77B 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
United Therapeutics USD 436.8M 34.2M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Biogen - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.